Gainers
- Apellis Pharmaceuticals (NASDAQ:APLS) stock rose 33.3% to $41.0 during Tuesday's after-market session. Apellis Pharmaceuticals's trading volume hit 850.1K shares by close, accounting for 19.9% of its average volume over the last 100 days. The market value of their outstanding shares is at $4.8 billion.
- Immix Biopharma (NASDAQ:IMMX) stock increased by 13.33% to $2.04. The company's market cap stands at $33.2 million.
- Fortress Biotech (NASDAQ:FBIO) shares moved upwards by 9.14% to $0.46. The market value of their outstanding shares is at $60.8 million.
- Beyond Air (NASDAQ:XAIR) shares moved upwards by 9.05% to $2.89. The company's market cap stands at $91.6 million.
- SenesTech (NASDAQ:SNES) shares moved upwards by 8.41% to $0.76. The market value of their outstanding shares is at $2.2 million.
- Sonnet BioTherapeutics (NASDAQ:SONN) shares moved upwards by 8.26% to $0.3. This security traded at a volume of 318.2K shares come close, making up 7.8% of its average volume over the last 100 days. The company's market cap stands at $11.5 million.
Losers
- Renovaro Biosciences (NASDAQ:RENB) stock decreased by 9.8% to $1.94 during Tuesday's after-market session. The company's market cap stands at $123.5 million.
- SeqLL (NASDAQ:SQL) stock decreased by 8.29% to $0.32. The company's market cap stands at $4.4 million.
- Vincerx Pharma (NASDAQ:VINC) stock fell 7.61% to $0.85. Trading volume for this security closed at 1.1 million, accounting for 1046.2% of its average full-day volume over the last 100 days. The market value of their outstanding shares is at $18.1 million.
- Poseida Therapeutics (NASDAQ:PSTX) stock decreased by 7.07% to $2.34. The market value of their outstanding shares is at $222.7 million.
- Lucy Scientific Discovery (NASDAQ:LSDI) stock declined by 7.05% to $0.63. The company's market cap stands at $10.9 million.
- Mesoblast (NASDAQ:MESO) shares declined by 5.41% to $1.4. Today's trading volume for this security ended up closing at 53.0K shares, which is 11.4 percent of its average volume over the last 100 days. The market value of their outstanding shares is at $227.8 million. See Also: www.benzinga.com/money/best-healthcare-stocks/
This article was generated by Benzinga's automated content engine and reviewed by an editor.
Market News and Data brought to you by Benzinga APIs
© 2025 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
